Astrazeneca PLC Description
AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for cardiovascular, gastrointestinal, neuroscience, infection, oncology, and respiratory and inflammation diseases worldwide. Its principal products include Atacand for hypertension and heart failure; Crestor for managing cholesterol levels; Seloken/Toprol-XL for hypertension, heart failure, and angina; Nexium for acid reflux; Synagis for RSV, a respiratory infection in infants; Seroquel IR for schizophrenia and bipolar disorders; and Seroquel XR for schizophrenia, bipolar disorder, and major depressive disorders. The company principal products also comprise Zoladex for prostate and breast cancer; Pulmicort for asthma and chronic obstructive pulmonary diseases; and Symbicort for asthma and chronic obstructive pulmonary diseases. In addition, it has 84 pipeline projects, which include 71 projects in various clinical phases of development. The company markets its products to primary care and specialist doctors through distributors or local representative offices. AstraZeneca PLC has collaboration agreements with Amgen, Inc. to develop and commercialize monoclonal antibodies; Ironwood Pharmaceuticals, Inc to co-develop and co-commercialize linaclotide in China; BIND Therapeutics, Inc. to develop and commercialize cancer nanomedicine; and WuXi AppTec to develop and commercialize MEDI5117, a biologic for autoimmune and inflammatory diseases. It also has a strategic alliance with Isis Pharmaceuticals, Inc. for the discovery and development of novel generation antisense therapeutics; and a strategic collaboration with FibroGen, Inc. to develop and commercialize FG-4592, a compound for the treatment of anemia associated with chronic kidney disease and end-stage renal disease. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in London, the United Kingdom.
Classification
Sector:
Healthcare
Industry:
Drug Manufacturers - Major
Keywords:
Cancer
Nasdaq 100
Acid
Drugs
Antibodies
Neuroscience
Monoclonal Antibodies
Inflammation
Breast Cancer
Infection
Gastrointestinal
Hypertension
Psychoactive Drugs
Inflammatory Diseases
Kidney Disease
Heart Failure
Schizophrenia
Coronavirus
Asthma
Major Depressive Disorder
Chronic Obstructive Pulmonary Disease
Respiratory Diseases
Anemia
Cholesterol
Pulmonary Disease
Depressive Disorder
Primary Care
Chronic Kidney Disease
End Stage Renal Disease
Chronic Condition
Renal Disease
Stage Renal Disease
Autoimmune And Inflammatory Disease
Bipolar Disorder
Pulmonology
Angina
Nanomedicine
Respiratory Infection
Inflammation Diseases
Linaclotide